ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
PEREGRINE PHARMA
(NQ:
PPHM
)
1.700
USD
+0.080 (+4.94%)
Streaming Delayed Price
/ Updated:
1:11 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about PEREGRINE PHARMA
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Peregrine Pharmaceuticals Up 6.2%, Shares Break Through Resistance (PPHM)
Today 12:54 EDT
from
Comtex SmarTrend® News Briefs
Stocks to Watch (UniPixel Inc, Real Goods Solar, Peregrine Pharmaceuticals, Cimatron Ltd)
May 22, 2013
Austin, TX -- (SBWIRE) -- 05/22/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues...
Read More
from
SBWire - Latest Press Releases
Bio-Wire Equity Surveillance – Closing Bell 5/21/2013
May 21, 2013
Larger pharmaceutical companies generally kept their net gains in a modest range, with companies between $10-200B in market cap seeing gains within the range of +.5-1% while medium sized companies in...
Read More
category
TLON
,
PPHM
,
SCMP
, and 5 more.
from
Bio-Wire.Com
NASDAQ Decliners Watch List: The Medicines Company (NASDAQ:MDCO), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and SINA Corporation (NASDAQ:SINA) Added to
May 21, 2013
New York, NY -- (SBWIRE) -- 05/21/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding The Medicines Company (NASDAQ:MDCO), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM),...
Read More
from
SBWire - Latest Press Releases
Before the Crowd, How We Found JPM, PPHM, BSX and GLW
May 21, 2013
from
Marketwired News Releases
Mixed Open Ahead Of Apple's Testimony
May 21, 2013
The markets opened mixed with the Dow adding 7 points to 15,342 while Nasdaq slipped 6 points to 3490 ahead of Apple chief executive Tim Cook's testimony before the Senate's Permanent Subcommittee on...
Read More
category
Market News
from
MarketMinute.com Market Updates
Free Research Reports on CPB, JASO, PPHM and YHOO Issued by the Bedford Report
May 21, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity...
Read More
category
RPTP
,
ACAD
,
MDXG
, and 15 more.
from
Bio-Wire.Com
Peregrine Finalizes Phase III Trial Design
May 20, 2013
Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) reached an agreement with the Food and Drug Administration on the design of a Phase III trial for its lung cancer treatment bavituximab. Shares of the...
Read More
from
MarketMinute.com Stock News
Share Dealing : ELN, SIRI, RAD, PPHM
May 20, 2013
New York, NY -- (SBWIRE) -- 05/20/2013 -- Elan Corporation, (NYSE:ELN) is +0.405 - +3.47% from the previous close of $11.67. It traded between $11.75 - 12.21 with total traded volume of 22712728...
Read More
from
SBWire - Latest Press Releases
NASDAQ Gainers Watch List: Warner Chilcott Plc (NASDAQ:WCRX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) Added to Growing Stock Report's NASDAQ Gainer
May 20, 2013
New York, NY -- (SBWIRE) -- 05/20/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Warner Chilcott plc (NASDAQ:WCRX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and...
Read More
from
SBWire - Latest Press Releases
Research Reports on Hot Biotech Stocks: PPHM, ACAD, VNDA, BMY
May 20, 2013
New York, NY -- (SBWIRE) -- 05/20/2013 -- Peregrine Pharmaceuticals (NASDAQ:PPHM) is up 25.98% on strong trading today after starting the day at 1.83. PPHM closed previously at 1.54 and the strong...
Read More
from
SBWire - Latest Press Releases
Mixed Open After Records Last Week
May 20, 2013
The markets opened mixed with the Dow slipping 11 points to 15,342 while Nasdaq added 3 points to 3501 as investors took a breather after another record close last week.
Read More
category
Market News
from
MarketMinute.com Market Updates
Peregrine Pharma agrees with FDA on lung cancer trial design
May 20, 2013
May 20 (Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug.
Read More
category
companyNews
from
Reuters: Company News
Peregrine Pharma (PPHM) Pops Higher on Resumption
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353675 for the full story.
Read More
from
StreetInsider.com News Articles
Peregrine Pharma (PPHM) to resume trading at 9:15am ET
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353656 for the full story.
Read More
from
StreetInsider.com News Articles
Peregrine Pharma (PPHM), FDA Reach Agreement Over Bavituximab Phase III Design
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353432 for the full story.
Read More
from
StreetInsider.com News Articles
Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
May 20, 2013
Phase III Registration Trial of Investigational Immunotherapy Expected to Start by Year-End
Read More
from
Marketwired News Releases
Peregrine Pharmaceuticals, Inc. (PPHM) halted, news pending
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353414 for the full story.
Read More
from
StreetInsider.com News Articles
Celsion Corp. (NASDAQ:CLSN), EnteroMedics Inc. (NASDAQ:ETRM), and Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) Added to Equity Profile Report's NASDAQ Gainers Watch List.
May 17, 2013
Wilmington, DE -- (SBWIRE) -- 05/17/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Celsion Corp. (NASDAQ:CLSN), EnteroMedics Inc. (NASDAQ:ETRM), and Peregrine...
Read More
from
SBWire - Latest Press Releases
1 Stock to Buy, 1 Stock to Short: Small-Cap Pharma
May 17, 2013
Read More
category
NASDAQ:PPHM
,
NASDAQ:AGEN
from
InvestorPlace - Latest Headlines
StockCall Early Morning Insight into SQNM, PPHM, OPTR, ONXX, and INO
May 16, 2013
from
ACCESSWIRE
Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual Meeting
May 16, 2013
Presentations Include Data From Two Phase II Bavituximab Trials in Second-Line NSCLC and Pancreatic Cancer and a Phase I Bavituximab Trial in HER2-Negative Breast Cancer
Read More
from
Marketwired News Releases
Hot Stock: Peregrine Pharmaceuticals, Shares Gain 5.3% (PPHM)
May 13, 2013
from
Comtex SmarTrend® News Briefs
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The...
Read More
category
GALE
,
NVS
,
ONXX
, and 17 more.
from
Bio-Wire.Com
Peregrine Announces Completion of Patient Enrollment in Breast Cancer Clinical Trial for Bavituximab
April 29, 2013
Data From the Trial to Be Presented at 2013 ASCO Annual Meeting
Read More
from
Marketwired News Releases
Notable Movers - Applied DNA Sciences Inc, Neah Power Systems Inc, Peregrine Pharmaceuticals, Nuvilex Inc
April 26, 2013
Stamford, CT -- (SBWIRE) -- 04/26/2013 -- Jet Life Penny Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletters and...
Read More
from
SBWire - Latest Press Releases
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), Gentherm Incorporated (NASDAQ:THRM), Mecox Lane Limited (NASDAQ:MCOX), and Horizon Pharma, Inc. (NASDAQ:HZNP) Added to Growing Stock Report's NASDAQ Gain
April 19, 2013
New York, NY -- (SBWIRE) -- 04/19/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), Gentherm Incorporated (NASDAQ:THRM),...
Read More
from
SBWire - Latest Press Releases
Watch List: Brigus Gold, Endo Health Solutions, Questcor Pharmaceuticals, Peregrine Pharmaceuticals
April 18, 2013
Dallas, TX -- (SBWIRE) -- 04/18/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Stocks to Eyes On: Tesoro, KKR & Co., Peregrine Pharmaceuticals, US Airways Group
April 17, 2013
Dallas, TX -- (SBWIRE) -- 04/17/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
Google, Facebook, Yahoo, and Twitter: Web Giants Make Unexpected Announcements
Carol Kopp
2
Google and NASA Make Quantum Leap With New Computer
Josh Wolonick
3
Random Thoughts: The Third Dip Cometh!
Todd Harrison
4
Mother of All Fed Cha-Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
5
Every Trader and Investor Should Be Watching the Dollar
Tom Pizzuti and Kurt Hulse
See All Articles
»